Global Circulating Tumor Cells Market Insights, Forecast to 2025

Table of Contents

1 Study Coverage

• 1.1 Circulating Tumor Cells Product
• 1.2 Market Segments
• 1.3 Key Manufacturers Covered
• 1.4 Market by Type
  • 1.4.1 Global Circulating Tumor Cells Market Size Growth Rate by Product
  • 1.4.2 CTC Enrichment
  • 1.4.3 CTC Detection
  • 1.4.4 CTC Analysis
• 1.5 Market by End User
  • 1.5.1 Global Circulating Tumor Cells Market Size Growth Rate by End User
  • 1.5.2 Prostate Cancer
  • 1.5.3 Breast Cancer
  • 1.5.4 Colorectal Cancer
  • 1.5.5 Others
• 1.6 Study Objectives
• 1.7 Years Considered

2 Executive Summary

• 2.1 Global Circulating Tumor Cells Market Size
  • 2.1.1 Global Circulating Tumor Cells Revenue 2014-2025
  • 2.1.2 Global Circulating Tumor Cells Sales 2014-2025
• 2.2 Circulating Tumor Cells Growth Rate by Regions
  • 2.2.1 Global Circulating Tumor Cells Sales by Regions
  • 2.2.2 Global Circulating Tumor Cells Revenue by Regions

3 Breakdown Data by Manufacturers

• 3.1 Circulating Tumor Cells Sales by Manufacturers
  • 3.1.1 Circulating Tumor Cells Sales by Manufacturers
  • 3.1.2 Circulating Tumor Cells Sales Market Share by Manufacturers
  • 3.1.3 Global Circulating Tumor Cells Market Concentration Ratio (CR5 and HHI)
• 3.2 Circulating Tumor Cells Revenue by Manufacturers
  • 3.2.1 Circulating Tumor Cells Revenue by Manufacturers (2014-2019)
  • 3.2.2 Circulating Tumor Cells Revenue Share by Manufacturers (2014-2019)
• 3.3 Circulating Tumor Cells Price by Manufacturers
• 3.4 Circulating Tumor Cells Manufacturing Base Distribution, Product Types
  • 3.4.1 Circulating Tumor Cells Manufacturers Manufacturing Base Distribution, Headquarters
  • 3.4.2 Manufacturers Circulating Tumor Cells Product Type
  • 3.4.3 Date of International Manufacturers Enter into Circulating Tumor Cells Market
• 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product

• 4.1 Global Circulating Tumor Cells Sales by Product
• 4.2 Global Circulating Tumor Cells Revenue by Product
• 4.3 Circulating Tumor Cells Price by Product

5 Breakdown Data by End User

• 5.1 Overview
• 5.2 Global Circulating Tumor Cells Breakdown Data by End User

6 North America

• 6.1 North America Circulating Tumor Cells by Countries
  • 6.1.1 North America Circulating Tumor Cells Sales by Countries
  • 6.1.2 North America Circulating Tumor Cells Revenue by Countries
  • 6.1.3 United States
  • 6.1.4 Canada
  • 6.1.5 Mexico
• 6.2 North America Circulating Tumor Cells by Product
• 6.3 North America Circulating Tumor Cells by End User

7 Europe

• 7.1 Europe Circulating Tumor Cells by Countries
  • 7.1.1 Europe Circulating Tumor Cells Sales by Countries
  • 7.1.2 Europe Circulating Tumor Cells Revenue by Countries
  • 7.1.3 Germany
  • 7.1.4 France
  • 7.1.5 UK
  • 7.1.6 Italy
  • 7.1.7 Russia
• 7.2 Europe Circulating Tumor Cells by Product
• 7.3 Europe Circulating Tumor Cells by End User

8 Asia Pacific

• 8.1 Asia Pacific Circulating Tumor Cells by Countries
  • 8.1.1 Asia Pacific Circulating Tumor Cells Sales by Countries
  • 8.1.2 Asia Pacific Circulating Tumor Cells Revenue by Countries
  • 8.1.3 China
  • 8.1.4 Japan
  • 8.1.5 Korea
  • 8.1.6 India
  • 8.1.7 Australia
  • 8.1.8 Indonesia
  • 8.1.9 Malaysia
  • 8.1.10 Philippines
  • 8.1.11 Thailand
  • 8.1.12 Vietnam
  • 8.1.13 Singapore
• 8.2 Asia Pacific Circulating Tumor Cells by Product
• 8.3 Asia Pacific Circulating Tumor Cells by End User

9 Central & South America

• 9.1 Central & South America Circulating Tumor Cells by Countries
  • 9.1.1 Central & South America Circulating Tumor Cells Sales by Countries
  • 9.1.2 Central & South America Circulating Tumor Cells Revenue by Countries
  • 9.1.3 Brazil
• 9.2 Central & South America Circulating Tumor Cells by Product
• 9.3 Central & South America Circulating Tumor Cells by End User

10 Middle East and Africa

• 10.1 Middle East and Africa Circulating Tumor Cells by Countries
  • 10.1.1 Middle East and Africa Circulating Tumor Cells Sales by Countries
  • 10.1.2 Middle East and Africa Circulating Tumor Cells Revenue by Countries
  • 10.1.3 GCC Countries
  • 10.1.4 Turkey
  • 10.1.5 Egypt
  • 10.1.6 South Africa
• 10.2 Middle East and Africa Circulating Tumor Cells by Product
• 10.3 Middle East and Africa Circulating Tumor Cells by End User

11 Company Profiles

• 11.1 Janssen
  • 11.1.1 Janssen Company Details
  • 11.1.2 Company Business Overview
  • 11.1.3 Janssen Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.1.4 Janssen Circulating Tumor Cells Products Offered
  • 11.1.5 Janssen Recent Development
• 11.2 Qiagen（Adnagen）
  • 11.2.1 Qiagen（Adnagen） Company Details
  • 11.2.2 Company Business Overview
  • 11.2.3 Qiagen（Adnagen） Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.2.4 Qiagen（Adnagen） Circulating Tumor Cells Products Offered
  • 11.2.5 Qiagen（Adnagen） Recent Development
• 11.3 Acousys Biodevices
  • 11.3.1 Acousys Biodevices Company Details
  • 11.3.2 Company Business Overview
  • 11.3.3 Acousys Biodevices Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.3.4 Acousys Biodevices Circulating Tumor Cells Products Offered
  • 11.3.5 Acousys Biodevices Recent Development
• 11.4 ApoCell
  • 11.4.1 ApoCell Company Details
  • 11.4.2 Company Business Overview
  • 11.4.3 ApoCell Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.4.4 ApoCell Circulating Tumor Cells Products Offered
  • 11.4.5 ApoCell Recent Development
• 11.5 Advanced Cell Diagnostics
  • 11.5.1 Advanced Cell Diagnostics Company Details
  • 11.5.2 Company Business Overview
  • 11.5.3 Advanced Cell Diagnostics Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.5.4 Advanced Cell Diagnostics Circulating Tumor Cells Products Offered
  • 11.5.5 Advanced Cell Diagnostics Recent Development
• 11.6 Fluxion Biosciences
  • 11.6.1 Fluxion Biosciences Company Details
  • 11.6.2 Company Business Overview
  • 11.6.3 Fluxion Biosciences Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.6.4 Fluxion Biosciences Circulating Tumor Cells Products Offered
  • 11.6.5 Fluxion Biosciences Recent Development
• 11.7 Biocept
  • 11.7.1 Biocept Company Details
  • 11.7.2 Company Business Overview
  • 11.7.3 Biocept Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.7.4 Biocept Circulating Tumor Cells Products Offered
  • 11.7.5 Biocept Recent Development
• 11.8 Fluidigm
  • 11.8.1 Fluidigm Company Details
  • 11.8.2 Company Business Overview
  • 11.8.3 Fluidigm Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.8.4 Fluidigm Circulating Tumor Cells Products Offered
  • 11.8.5 Fluidigm Recent Development
• 11.9 Epic Sciences
  • 11.9.1 Epic Sciences Company Details
  • 11.9.2 Company Business Overview
  • 11.9.3 Epic Sciences Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.9.4 Epic Sciences Circulating Tumor Cells Products Offered
  • 11.9.5 Epic Sciences Recent Development
• 11.10 Clearbridge Biomedics
  • 11.10.1 Clearbridge Biomedics Company Details
  • 11.10.2 Company Business Overview
  • 11.10.3 Clearbridge Biomedics Circulating Tumor Cells Sales, Revenue and Gross Margin (2014-2019)
  • 11.10.4 Clearbridge Biomedics Circulating Tumor Cells Products Offered
  • 11.10.5 Clearbridge Biomedics Recent Development
• 11.11 Cynvenio
• 11.12 CytoTrack
• 11.13 ScreenCell
• 11.14 Creatv Microtech
• 11.15 Aviva Biosciences
• 11.16 Greiner Bio-one
• 11.17 Sysmex
• 11.18 Ikonisys

12 Future Forecast

• 12.1 Circulating Tumor Cells Market Forecast by Regions
  • 12.1.1 Global Circulating Tumor Cells Sales Forecast by Regions 2019-2025
  • 12.1.2 Global Circulating Tumor Cells Revenue Forecast by Regions 2019-2025
• 12.2 Circulating Tumor Cells Market Forecast by Product
  • 12.2.1 Global Circulating Tumor Cells Sales Forecast by Product 2019-2025
  • 12.2.2 Global Circulating Tumor Cells Revenue Forecast by Product 2019-2025
• 12.3 Circulating Tumor Cells Market Forecast by End User
• 12.4 North America Circulating Tumor Cells Forecast
• 12.5 Europe Circulating Tumor Cells Forecast
• 12.6 Asia Pacific Circulating Tumor Cells Forecast
• 12.7 Central & South America Circulating Tumor Cells Forecast
• 12.8 Middle East and Africa Circulating Tumor Cells Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

• 13.1 Market Opportunities and Drivers
• 13.2 Market Challenges
• 13.3 Market Risks/Restraints
• 13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis

• 14.1 Value Chain Analysis
• 14.2 Circulating Tumor Cells Customers
• 14.3 Sales Channels Analysis
  • 14.3.1 Sales Channels
  • 14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details